 |
BioWorld-International-2006-12-13
Blindness Gene Identified In Chickens Could Have Impact
Newron Raises CHF118.12M In Swiss Initial Public Offering
Shares in Newron Pharmaceuticals SpA opened on the Swiss Stock Exchange in Zurich at CHF58 (US$48.20) Tuesday, more than 5 percent above its initial public offering price of CHF55 per share. (BioWorld International)